Oliver Lagore Vanvalin Investment Group Astrazeneca PLC Transaction History
Oliver Lagore Vanvalin Investment Group
- $263 Million
- Q2 2025
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Astrazeneca PLC stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 11,039 shares of AZN stock, worth $831,678. This represents 0.29% of its overall portfolio holdings.
Number of Shares
11,039
Previous 16,420
32.77%
Holding current value
$831,678
Previous $1.08 Million
28.28%
% of portfolio
0.29%
Previous 0.29%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,417Shares Held
510MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.3 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.68 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.4 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.36 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...